Defining the role of Drip27, a novel long noncoding RNA, in erythropoiesis

定义 Drip27(一种新型长非编码 RNA)在红细胞生成中的作用

基本信息

  • 批准号:
    8968039
  • 负责人:
  • 金额:
    $ 15.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-27 至 2020-05-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): This application describes the candidate's research on the genetics of red blood cell development (erythropoiesis) to be performed within the context of a 5-year mentored career development plan. His ultimate goal is to become an independent physician-scientist in the area of laboratory-based, academic hematology- oncology. Under the guidance of his primary research mentor Dr. Gerd Blobel at the Children's Hospital of Philadelphia (CHOP), and his co-mentor Dr. Mitchell Weiss at St. Jude Children's Research Hospital, Dr. Paralkar has developed a structured training plan consisting of intensive laboratory research, coursework in RNA biology and bioinformatics, regular participation at scientific conferences, and oversight by an experienced faculty advisory committee. Drs. Blobel and Weiss have extensive experience in training scientists and physician-scientists, and the educational/training environments at CHOP and the University of Pennsylvania are outstanding. Dr. Paralkar's laboratory work centers on long non-coding RNAs (LncRNAs), a recently appreciated class of genetic material that modulates gene expression and regulates diverse aspects of normal and pathological mammalian development. Thousands of LncRNAs are believed to exist, but only few have been studied in detail. Dr. Paralkar has identified a novel LncRNA named Drip27 that regulates the critical cell cycle inhibitor p27. This proposal investigates the hypothesis that Drip27 LncRNA directly activates p27 transcription, and thereby regulates cell division and replication during erythropoiesis. The long term goal of this research is to define the role of Drip27 in normal hematopoietic development and associated diseases such as blood cancers. In preliminary studies, Dr. Paralkar used comprehensive RNA-Sequencing and bioinformatic tools to identify hundreds of novel LncRNAs in mouse and human erythroid precursors. He chose a novel conserved LncRNA named `Drip27,' and he used CRISPR technology to delete it in an erythroid cell line. Deletion led to a significant reduction i the expression of the crucial cell cycle inhibitor p27. This proposal aims to study the effect of Drip27 transcript loss on erythropoiesis by generating mouse ES cells with truncated Drip27 transcript and differentiating them into erythroblasts (Aim 1). The mechanisms by which Drip27 functions will be examined by imaging the subcellular localization of Drip27 RNA molecules and by assessing for the presence of chromosomal looping between the Drip27 and the p27 loci (Aim 2). Published work demonstrates that many LncRNAs regulate gene expression through physical interactions with transcription factors/co-factors/chromatin modifying complexes that orchestrate global gene expression. To further define the mechanism by which Drip27 acts on the p27 locus, proteins binding to Drip27 will be identified (Aim 3). These three aims, put together, will establish the role played by Drip27 in erythropoiesis and the mechanism by which it regulates its target gene. If successful, this work will illuminate novel regulatory mechanisms in erythropoiesis and paradigms for noncoding RNA function. In turn, these findings are likely to produce insights into various blood diseases including anemias, myeloproliferative disorders and myelodysplastic syndromes. Performing this research in the context of a rigorous formal training plan within a highly supportive academic enviroment will provide the candidate essential data and professional tools for advancement into an independent position as a research oriented academic physician-scientist.
 描述(由申请人提供):本申请描述了候选人对红细胞发育(红细胞生成)遗传学的研究,该研究将在5年指导职业发展计划的背景下进行。他的最终目标是成为一名独立的医生,科学家在该地区的实验室为基础的,学术血液学-肿瘤学。在费城儿童医院(CHOP)的主要研究导师Gerd Blobel博士和St. Jude儿童研究医院的共同导师Mitchell韦斯博士的指导下,Paralkar博士制定了一个结构化的培训计划,包括密集的实验室研究,RNA生物学和生物信息学课程,定期参加科学会议,并由经验丰富的教师咨询委员会监督。Blobel和韦斯博士在培训科学家和医学科学家方面拥有丰富的经验,CHOP和宾夕法尼亚大学的教育/培训环境非常出色。Paralkar博士的实验室工作集中在长非编码RNA(LncRNA)上,这是一种最近受到重视的遗传物质,可调节基因表达并调节正常和病理性哺乳动物发育的各个方面。据信存在数千种LncRNA,但只有少数被详细研究。Paralkar博士发现了一种名为Drip 27的新型LncRNA,它可以调节关键的细胞周期抑制剂p27。该提案研究了Drip 27 LncRNA直接激活p27转录,从而调节红细胞生成过程中的细胞分裂和复制的假设。这项研究的长期目标是确定Drip 27在正常造血发育和相关疾病(如血癌)中的作用。在初步研究中,Paralkar博士使用全面的RNA测序和生物信息学工具来鉴定小鼠和人类红细胞前体中的数百种新型LncRNA。他选择了一种名为“Drip 27”的新型保守LncRNA,并使用CRISPR技术在红细胞系中删除了它。缺失导致关键的细胞周期抑制因子p27的表达显著降低。该提案旨在通过产生具有截短的Drip 27转录物的小鼠ES细胞并将其分化成成红细胞来研究Drip 27转录物缺失对红细胞生成的影响(目的1)。将通过对Drip 27 RNA分子的亚细胞定位进行成像,并通过评估Drip 27和p27基因座之间是否存在染色体环来检查Drip 27发挥功能的机制(目的2)。已发表的工作表明,许多LncRNA通过与转录因子/辅因子/染色质修饰复合物的物理相互作用来调节基因表达,所述转录因子/辅因子/染色质修饰复合物协调全局基因表达。为了进一步确定Drip 27作用于p27基因座的机制,将鉴定与Drip 27结合的蛋白质(目的3)。这三个目标放在一起,将建立Drip 27在红细胞生成中的作用及其调节靶基因的机制。如果成功,这项工作将阐明红细胞生成和非编码RNA功能范例的新调控机制。反过来,这些发现可能会产生对各种血液疾病的见解,包括贫血,骨髓增生性疾病和骨髓增生异常综合征。在一个严格的正式培训计划的背景下,在一个高度支持的学术环境中进行这项研究将为候选人提供必要的数据和专业工具,以促进成为一个独立的位置,作为一个以研究为导向的学术物理学家,科学家。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Vikram R. Paralkar其他文献

Evolving racial/ethnic disparities in AML survival in the novel therapy era
新型治疗时代急性髓系白血病(AML)生存率中不断变化的种族/民族差异
  • DOI:
    10.1182/bloodadvances.2024014127
  • 发表时间:
    2025-02-11
  • 期刊:
  • 影响因子:
    7.100
  • 作者:
    Xin Wang;Phyllis A. Gimotty;Andrew H. Matthews;Ronac Mamtani;Selina M. Luger;Elizabeth O. Hexner;Daria V. Babushok;Shannon R. McCurdy;Noelle V. Frey;Ximena Jordan Bruno;Saar Gill;Mary Ellen Martin;Vikram R. Paralkar;Ivan Maillard;David L. Porter;Alison W. Loren;Alexander E. Perl;Keith W. Pratz;Kelly D. Getz;Catherine Lai
  • 通讯作者:
    Catherine Lai

Vikram R. Paralkar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Vikram R. Paralkar', 18)}}的其他基金

The Role of PHF6 in HSC self-renewal and myeloid expansion
PHF6 在 HSC 自我更新和骨髓扩张中的作用
  • 批准号:
    10540364
  • 财政年份:
    2021
  • 资助金额:
    $ 15.68万
  • 项目类别:
The Role of PHF6 in HSC self-renewal and myeloid expansion
PHF6 在 HSC 自我更新和骨髓扩张中的作用
  • 批准号:
    10095975
  • 财政年份:
    2021
  • 资助金额:
    $ 15.68万
  • 项目类别:
The Role of PHF6 in HSC self-renewal and myeloid expansion
PHF6 在 HSC 自我更新和骨髓扩张中的作用
  • 批准号:
    10322090
  • 财政年份:
    2021
  • 资助金额:
    $ 15.68万
  • 项目类别:
Regulation of rRNA transcription in mammalian tissues
哺乳动物组织中 rRNA 转录的调控
  • 批准号:
    10797499
  • 财政年份:
    2020
  • 资助金额:
    $ 15.68万
  • 项目类别:
Regulation of rRNA transcription in mammalian tissues
哺乳动物组织中 rRNA 转录的调控
  • 批准号:
    10028009
  • 财政年份:
    2020
  • 资助金额:
    $ 15.68万
  • 项目类别:
Regulation of rRNA transcription in mammalian tissues
哺乳动物组织中 rRNA 转录的调控
  • 批准号:
    10680404
  • 财政年份:
    2020
  • 资助金额:
    $ 15.68万
  • 项目类别:
Regulation of rRNA transcription in mammalian tissues
哺乳动物组织中 rRNA 转录的调控
  • 批准号:
    10459512
  • 财政年份:
    2020
  • 资助金额:
    $ 15.68万
  • 项目类别:
Regulation of rRNA transcription in mammalian tissues
哺乳动物组织中 rRNA 转录的调控
  • 批准号:
    10245252
  • 财政年份:
    2020
  • 资助金额:
    $ 15.68万
  • 项目类别:

相似国自然基金

基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
  • 批准号:
    82302715
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
  • 批准号:
    31200592
  • 批准年份:
    2012
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
  • 批准号:
    24K10442
  • 财政年份:
    2024
  • 资助金额:
    $ 15.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
  • 批准号:
    23K15297
  • 财政年份:
    2023
  • 资助金额:
    $ 15.68万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Fanconi anemia経路に着目したiPS細胞における高レベル複製ストレスの原因解明
阐明 iPS 细胞中高水平复制应激的原因,重点关注范可尼贫血途径
  • 批准号:
    23K14452
  • 财政年份:
    2023
  • 资助金额:
    $ 15.68万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Analysis of the mechanism of hemolytic anemia in canine babesiosis and development of novel therapeutic measures
犬巴贝斯虫病溶血性贫血机制分析及新治疗措施开发
  • 批准号:
    23KJ0074
  • 财政年份:
    2023
  • 资助金额:
    $ 15.68万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Mobile phone-based screening for anemia in young children in western Kenya
基于手机的肯尼亚西部幼儿贫血筛查
  • 批准号:
    10752968
  • 财政年份:
    2023
  • 资助金额:
    $ 15.68万
  • 项目类别:
Brain blood flow, oxygenation, and cognition in adult onset iron deficiency anemia
成人缺铁性贫血的脑血流量、氧合和认知
  • 批准号:
    10735765
  • 财政年份:
    2023
  • 资助金额:
    $ 15.68万
  • 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
  • 批准号:
    10735366
  • 财政年份:
    2023
  • 资助金额:
    $ 15.68万
  • 项目类别:
Accuracy and Feasibility of Non-Invasive Anemia Screening Assistant (ASIST) Device in Resource-Limited Settings
资源有限环境中非侵入性贫血筛查辅助 (ASIST) 设备的准确性和可行性
  • 批准号:
    10575222
  • 财政年份:
    2023
  • 资助金额:
    $ 15.68万
  • 项目类别:
Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury
新生儿贫血中的肝肠轴及其在红细胞输注相关肠道损伤中的作用
  • 批准号:
    10583807
  • 财政年份:
    2023
  • 资助金额:
    $ 15.68万
  • 项目类别:
A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
  • 批准号:
    10564553
  • 财政年份:
    2023
  • 资助金额:
    $ 15.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了